Physiol. Genomics Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 24: 144-153, 2006. First published November 29, 2005; doi:10.1152/physiolgenomics.00258.2005 Free Article
1094-8341/06 $8.00
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure and Tables
Right arrowFree Article All Versions of this Article:
24/2/144    most recent
00258.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, Y.
Right arrow Articles by Sutter, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Y.
Right arrow Articles by Sutter, T. R.
Received 17 October 2005; accepted in final form 23 November 2005.
Physiological Genomics 24:144-153 (2006)
1094-8341/05 $8.00 © 2006 American Physiological Society

Identification of novel transcriptional networks in response to treatment with the anticarcinogen 3H-1,2-dithiole-3-thione

Yong Huang 1, Jian Yan 1, Ronald Lubet 2, Thomas W. Kensler 3 and Thomas R. Sutter 1

1 W. Harry Feinstone Center for Genomic Research, University of Memphis, Memphis, Tennessee
2 Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, Maryland
3 Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland

3H-1,2-dithiole-3-thione (D3T), an inducer of antioxidant and phase 2 genes, is known to enhance the detoxification of environmental carcinogens, prevent neoplasia, and elicit other protective effects. However, a comprehensive view of the regulatory pathways induced by this compound has not yet been elaborated. Fischer F344 rats were gavaged daily for 5 days with vehicle or D3T (0.3 mmol/kg). The global changes of gene expression in liver were measured with Affymetrix RG-U34A chips. With the use of functional class scoring, a semi-supervised method exploring both the expression pattern and the functional annotation of the genes, the Gene Ontology classes were ranked according to the significance of the impact of D3T treatment. Two unexpected functional classes were identified for the D3T treatment, cytosolic ribosome constituents with 90% of those genes increased, and cholesterol biosynthesis with 91% of the genes repressed. In another novel approach, the differentially expressed genes were evaluated by the Ingenuity computational pathway analysis tool to identify specific regulatory networks and canonical pathways responsive to D3T treatment. In addition to the known glutathione metabolism pathway (P = 0.0011), several other significant pathways were also revealed, including antigen presentation (P = 0.000476), androgen/estrogen biosynthesis (P = 0.000551), fatty acid (P = 0.000216), and tryptophan metabolism (P = 0.000331) pathways. These findings showed a profound impact of D3T on lipid metabolism and anti-inflammatory/immune-suppressive response, indicating a broader cytoprotective effect of this compound than previously expected.

functional cluster scoring; Gene Ontology; Ingenuity Pathways Knowledge Database; canonical pathway; Nrf2




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. S. Yates, Q. T. Tran, P. M. Dolan, W. O. Osburn, S. Shin, C. C. McCulloch, J. B. Silkworth, K. Taguchi, M. Yamamoto, C. R. Williams, et al.
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice
Carcinogenesis, June 1, 2009; 30(6): 1024 - 1031.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Q. T. Tran, L. Xu, V. Phan, S. B. Goodwin, M. Rahman, V. X. Jin, C. H. Sutter, B. D. Roebuck, T. W. Kensler, E.O. George, et al.
Chemical genomics of cancer chemopreventive dithiolethiones
Carcinogenesis, March 1, 2009; 30(3): 480 - 486.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. M. Olsen, Y. Huang, S. Goodwin, D. C. Ciobanu, L. Lu, T. R. Sutter, and D. G. Winder
Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum
Physiol Genomics, February 19, 2008; 32(3): 283 - 298.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. K. Cho, W. D. Kim, S. H. Ki, J.-I. Hwang, S. Choi, C. H. Lee, and S. G. Kim
Role of G{alpha}12 and G{alpha}13 as Novel Switches for the Activity of Nrf2, a Key Antioxidative Transcription Factor
Mol. Cell. Biol., September 1, 2007; 27(17): 6195 - 6208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.